MEASUREMENT PROPERTIES OF PAINDETECT BY SEVERITY OF NEUROPATHIC PAIN

Author(s)

Sadosky A1, Cappelleri JC2, Parliyan A3, Koduru V4
1Pfizer, New York, NY, USA, 2Pfizer Global Pharmaceuticals, New York, NY, USA, 3Pfizer, Inc., New York, NY, USA, 4Eliassen Group, New London, CT, USA

OBJECTIVES: To evaluate whether painDETECT, a screening questionnaire to identify neuropathic pain (NeP), can differentiate pain severity in patients with NeP. METHODS: Subjects (N=624; 55.4% male, 71.8% white, mean±SD age 55.5±13.7 years) with confirmed diagnoses of NeP were identified during routine office visits to U.S. community-based physicians. The Brief Pain Inventory was used to stratify subjects by mild (score 0-3; n=110), moderate (score 4-6; n=297), and severe (score 7-10; n=207) pain. Scores on the 9-item painDETECT (seven pain symptom items, one pain course pattern item, and one pain irradiation item) range from -1 to 38; the 7-item painDETECT scores (only pain symptoms) range from 0 to 35. The ability of painDETECT to discriminate pain severity was evaluated using analysis of variance or covariance models (with Tukey’s adjustment for pairwise comparisons) to obtain unadjusted and adjusted (age, gender, race, ethnicity, time since NeP diagnosis, and number of comorbidities) mean painDETECT scores. Cumulative distribution functions on painDETECT scores by pain severity were compared (Kolmogorov-Smirov test). Cronbach’s alpha assessed internal consistency reliability. RESULTS: Unadjusted mean scores were 14.3 for mild, 18.6 for moderate, and 22.7 for severe pain for the 7-items, and 15.2, 19.8, and 24.0, respectively, for the 9-items. Adjusted 7-item mean scores for mild, moderate and severe pain were 16.4, 20.1 and 24.0, respectively, and adjusted 9-item mean scores were 17.3, 21.3 and 25.3, respectively. All pairwise comparisons of mean scores between pain severity groups were statistically significant (P<0.0001). Cumulative distribution functions showed distinct separation between pain severity groups (P<0.0001). Cronbach’s alphas were 0.80 and 0.76, for the 7- and 9-item scales, respectively. CONCLUSIONS: This study is the first to provide strong psychometric evidence on the validity and reliability of painDETECT for distinguishing severity of NeP, further supporting its clinical relevance for identifying and characterizing NeP.

Conference/Value in Health Info

2014-05, ISPOR 2014, Palais des Congres de Montreal

Value in Health, Vol. 17, No. 3 (May 2014)

Code

PRM104

Topic

Methodological & Statistical Research

Topic Subcategory

PRO & Related Methods

Disease

Neurological Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×